You are here

Europe Specialty Generics Market Report 2019: Market Reached a Value of US$ 13.2 Billion in 2018 and is Expected to Reach US$ 21.9 Billion by 2024

DUBLIN, May 30, 2019 /PRNewswire/ -- The "Europe Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

Europe specialty generics market reached a value of US$ 13.2 Billion in 2018

Specialty generics are classified as high-cost, high complexity and/or high touch generics. They are the generic versions of speciality branded drugs after they lose their patent protection. Specialty generics are used to treat complex diseases which may be chronic by nature and life-threatening like hepatitis C, cancer, rheumatoid arthritis, multiple sclerosis, etc.

Driven by factors such as an increasing aging population, changing lifestyles and a rising prevalence of chronic diseases, healthcare costs in Europe have increased significantly in recent years creating a huge burden on the government, healthcare providers and patients. Specialty generics are playing a major role in the region to reduce this cost burden as they are more cost-effective as compared to their branded versions.

Unlike branded speciality drugs, specialty generics don't require expensive and time-consuming research and development procedures. Additionally, they also don't incur the same amount of marketing and promotional expenses, resulting in substantially lower costs. In addition to this, the patent expiration of several blockbuster specialty drugs is expected to expire in the coming years creating a positive impact on the market.

Looking forward, the market value to reach US$ 21.9 Billion by 2024, exhibiting a CAGR of around 9% during 2019-2024.

Key Questions Answered in This Report:

  • How has the European specialty generics market performed so far and how will it perform in the coming years?
  • What is the breakup of the European specialty generics market based on the region?
  • What is the breakup of the European specialty generics market based on the route of administration?
  • What is the breakup of the European specialty generics market based on the indication?
  • What is the breakup of European specialty generics market based on the distribution channel?
  • What are the various stages in the value chain of the specialty generics industry?
  • What are the key driving factors and challenges in the European specialty generics market?
  • What is the structure of the European specialty generics industry and who are the key players?
  • What is the degree of competition in the European specialty generics market?

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction
4.1 What are Specialty Generic Drugs?
4.2 Types of Specialty Generics

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market
6.1 Market Overview
6.2 Market Performance
6.3 Market Breakup by Route of Administration
6.4 Market Breakup by Indication
6.5 Market Breakup by Distribution Channel
6.6 Market Breakup by Region
6.7 Market Forecast

7 Europe Specialty Generics Market
7.1 Market Overview
7.2 Market Performance
7.3 Market Breakup by Route of Administration
7.4 Market Breakup by Indication
7.5 Market Breakup by Distribution Channel
7.6 Market Breakup by Region
7.7 Market Forecast
7.8 SWOT Analysis
7.9 Value Chain Analysis
7.10 Porters Five Forces Analysis
7.11 Key Market Drivers and Success Factors

8 Market Breakup by Route of Administration
8.1 Injectable
8.2 Oral
8.3 Others

9 Market Breakup by Indication
9.1 Oncology
9.2 Autoimmune Diseases
9.3 Infectious Diseases
9.4 Others

10 Market Breakup by Distribution Channel
10.1 Retail Pharmacies
10.2 Specialty Pharmacies
10.3 Hospital Pharmacies

11 Market Breakup by Region
11.1 Italy
11.2 Germany
11.3 France
11.4 United Kingdom
11.5 Spain
11.6 Rest of Europe

12 Competitive Landscape
12.1 Market Structure
12.2 Key Players
12.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/e45noc

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/europe-specialty-generics-market-report-2019-market-reached-a-value-of-us-13-2-billion-in-2018-and-is-expected-to-reach-us-21-9-billion-by-2024--300858413.html

SOURCE Research and Markets